Study of plasma, urine and gastric juice concentrations of famotidine using high performance liquid chromatography
M Bologna1, L Biordi, T Napolitano
1Department of Biomedical Sciences, University of Aquila, Italy.
Abstract:
An improved method for the high performance liquid chromatography (HPLC) determination of famotidine, a recently introduced inhibitor of histamine H2-receptors, has been devised. Plasma, urine and gastric juice concentrations of famotidine have been measured in a series of 46 patients hospitalized for gastrointestinal disorders and for other unrelated pathologies, after a single oral dose of 40 mg. Pharmacokinetic data confirmed previously described trends of distribution and metabolism of famotidine, attaining peak plasma levels 1.5-2.0 h after oral administration and high urine levels, in unmodified form, between two and twelve hours. This simple HPLC method may be adopted for monitoring plasma concentrations of famotidine in patients, for assessing patient compliance in taking the drug by measuring urine levels and for examining the relationship between plasma famotidine concentration and the antisecretory effect.
More Related Videos
10:17High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
14:39Semi-Targeted Ultra-High-Performance Chromatography Coupled to Mass Spectrometry Analysis of Phenolic Metabolites in Plasma of Elderly Adults
Published on: April 22, 2022
Related Concept Videos
Drug Distribution: Plasma Protein Binding
High-Performance Liquid Chromatography: Types of Detectors
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Drug Concentrations: Measurements
Plasma —...
Measurement of Bioavailability: Pharmacokinetic Methods
